
01 October 2026Event
Brussels HLS Day
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition
ECCTA is a wide-ranging piece of legislation, addressing a number of issues, but broadly themed around measures to prevent financial crime and to promote transparency in the ownership and use of corporate structures. It contains diverse and unrelated provisions, some of which came into force immediately in December 2023, while others will be brought into force throughout 2024 and into 2025.
Companies and partnerships will need to take steps to address some of what ECCTA brings immediately, while other changes cannot effectively be addressed until they are clarified by secondary legislation or government guidance.
This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.
If you have any questions, contact a member of the Economic Crime and Corporate Transparency Act team for assistance:

01 October 2026Event
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition

02 July 2026 Event
Join our upcoming event that will feature speakers from J.P. Morgan, Bank of America, and Simmons & Simmons

11 June 2026 Event
Join our webinar to be up-to-date with the regulatory developments in the asset management sector

10 June 2026 Publication
Following the fourth session in our webinar series, our team has prepared a guide with key takeaways on professional services and decision-making

09 June 2026 Publication
CSSF sets out enhanced expectations on valuation frameworks for illiquid assets, focusing on governance, models, controls and risk-based approaches for IFMs